Trademark Overview
On Wednesday, April 8, 2026, a trademark application was filed for FREXWAYVO with the United States Patent and Trademark Office. The USPTO has given the FREXWAYVO trademark a serial number of 99750838. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, April 8, 2026. This trademark is owned by Sanofi. The FREXWAYVO trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment and prevention of autoimmune, immune-mediated, inflammatory and immunological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the central nervous system; Pharmaceutical preparations for the treatment and prevention of rare autoimmune, immune-mediated, inflammatory, immunological, central nervous system and neurological diseases and disorders